U.S. Physical Therapy, Inc. (USPH) — Fair Value Analysis
Base-case fair value (P50): $62.27 · Current price: $63.73 · Verdict: Fairly Valued
The Verdict on USPH
US Physical Therapy Inc (USPH) is currently assessed as Fairly Valued based on our rigorous Monte Carlo simulations. The current market price of $63.73 sits closely aligned with our median fair value (P50) of $62.27. This indicates a marginal -2.3% relative to its fundamental valuation, suggesting the market has largely priced in the company's expected performance and risk profile. Our analysis, which models thousands of future financial scenarios, consistently points to a valuation that offers little immediate arbitrage from the current trading level. Investors should consider that this tight alignment between market price and median fair value implies that substantial upward movement from current levels might require unexpected positive catalysts.
How USPH stacks up against peers
While a specific sector isn't provided for USPH, its operational and financial health is categorized as strong. This robust quality tier signals a resilient business model and sound financial management compared to its general peer group. Despite this strong underlying quality, the simulations show the company's $63.73 of $63.73 is already reflecting much of that intrinsic strength. This positioning, where a high-quality asset trades near its P50 fair value of $62.27 with a minor -2.3%, suggests that while USPH is a solid enterprise, its current valuation leaves little room for undervaluation-driven upside. Prudent investors often look for a greater discount or a significant P50 upside, even for strong companies.
What this means for investors
For investors weighing USPH, the analysis suggests a balanced outlook. The proximity of $63.73 to the $62.27 fair value, underscored by the -2.3%, indicates that the stock is neither significantly overvalued nor undervalued at this juncture. Given its strong quality tier, USPH presents as a fundamentally sound company trading near its intrinsic value. While a downside scenario is always possible in market volatility, the Monte Carlo framework under FairCurve indicates the current price fairly represents the consensus of future possibilities. To fully understand the complete distribution, including specific bear and bull case targets and the probability of upside, sign up for a free FairCurve account to track USPH's fair value as new fundamentals are released.
Frequently Asked Questions
Is USPH overvalued or undervalued right now?
Based on our Monte Carlo simulations, USPH is currently considered Fairly Valued, with its current price of $63.73 closely aligning with our median fair value (P50) of $62.27.
What is the bear case and bull case for USPH?
The full Monte Carlo distribution, including specific bear (P10) and bull (P90) target prices, along with the probability of upside scenarios, is available to users with a free FairCurve account. We do not provide these specific values publicly.
How does FairCurve calculate USPH's fair value?
FairCurve calculates USPH's fair value through sophisticated Monte Carlo simulations, modeling thousands of forward-looking financial scenarios to derive a comprehensive distribution of potential intrinsic values.
How can I track USPH's fair value as it changes?
You can add USPH to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation alerts whenever new earnings reports or significant fundamental data are released.